Background: The outcome of tricuspid regurgitation (TR) remains unclear because of heterogeneity of etiology and the contradictory results of outcome studies. The aim of this study was to evaluate the clinical outcomes of TR in patients with pulmonary hypertension (PH) and normal left systolic function, stratified to patients with post-or precapillary PH.
monary artery systolic pressure Tricuspid regurgitation (TR) is a prevalent condition, 1 but management guidelines remain vague because of a paucity of outcome studies and their contradictory results. 2, 3 The etiology of TR is very heterogeneous, but commonly, the tricuspid valve is anatomically preserved, and significant regurgitation is mostly secondary to right ventricular (RV) enlargement (functional TR), resulting in tricuspid annular dilation or leaflet tethering. 4, 5 The prognostic impact of TR was shown to be substantial in a large heterogeneous group, 6 implying that tricuspid valve repair or replacement may lead to survival benefit. 2, 7 However, because mortality and morbidity are influenced by the same comorbidities affecting the tricuspid valve, concern was raised that the supposed harmful effect of TR may be just a surrogate marker for other cardiac or systemic comorbidities. Recent studies have tried to isolate TR from potential confounders and to assess outcomes for individual etiologies of TR separately. The results of these studies were surprising. On one hand, TR caused by flail leaflets, 8 TR associated with mitral rheumatic disease, 9 and isolated or idiopathic TR (functional TR with no left-sided valvular pathologies, preserved left ventricular ejection fraction [LVEF] , but without pulmonary hypertension [PH]) 10 significantly influenced survival. On the other hand, TR after left heart valve procedures, 11 following transcatheter aortic valve replacement, 12 or associated with systolic heart failure 13 was not associated with excess events after adjustment for comorbidities and RV dysfunction, suggesting that in these contexts it is just a surrogate marker for the associated comorbidities.
Patients with preserved LV systolic function and PH are separated into those with postcapillary PH due to heart failure with preserved LVEF and those with precapillary PH due to lung disease. They constitute a large proportion of patients with functional TR. In trying to assess whether TR is this clinical context is an independent associate of outcome (as in patients with idiopathic TR 10 ), suggesting a possible role for a ''TR-focused'' intervention, or just a surrogate marker of their primary disease (as in patients with systolic heart failure 13 ), we confined the present analysis to the well-defined, limited group of patients with preserved LVEF, PH, no left-sided valvular disease, and no other life expectancy-limiting conditions.
METHODS

Study Design
We retrospectively retrieved 2,381 consecutive echocardiogram from the Tel Aviv Medical Center cardiology unit performed between November 2011 and November 2014 fulfilling the following inclusion criteria: normal or preserved LVEF ($50%) and significant PH, defined as pulmonary artery systolic pressure $ 50 mm Hg. We excluded patients with significant valvular disease (any other native valve disease of grade moderate or greater, any rheumatic disease, any valvular surgery), any congenital heart disease, or severe comorbidities with limited life expectancy (end-stage kidney or liver disease, metastatic cancer). We also excluded repeat examinations of the same patient. The patient selection process is shown in Figure 1 . The final cohort consisted of 178 patients with at least moderate to severe TR compared with 67 patients with LVEF $ 50%, pulmonary systolic pressure $ 50 mm Hg, and less than mild TR. All valvular abnormalities were graded using the recent American Society of Echocardiography guidelines criteria. 2 
Clinical Characteristics and Outcomes
The records of all 245 patients were reviewed retrospectively. Comorbid conditions, medications, related physical examination findings, and demographic data were retrieved. Outcome was analyzed from an echocardiographic diagnosis until death or last follow-up to December 2016. In patients with several echocardiographic examinations, outcomes were analyzed from the first study with at least moderate to severe TR. Date of death was ascertained using the national health database, ensuring data accuracy. Cause of death was also noted. Cardiac death was defined as death related to acute coronary syndrome, heart failure, or arrhythmia. The study was powered (80%, P = .05) to detect a $30% mortality difference between at least moderate to severe and lesser degrees of TR. The study was institutional review board approved.
Echocardiography
Echocardiography was performed in a standard manner using the same equipment (iE33; Philips Medical Systems, Bothell, WA). From four-chamber views encompassing the entire right ventricle, end-systolic and end-diastolic RV areas and the tricuspid annulus were measured. Apart from qualitative grading, RV function was evaluated by tricuspid annular plane systolic excursion (TAPSE), RV endsystolic area, fractional area change (FAC), and index of myocardial performance (Tei index).
14 RV FAC was defined as (end-diastolic area À end-systolic area)/end-diastolic area and was obtained by tracing the RV endocardium in both systole and diastole from the annulus, along the free wall to the apex, and then back to the annulus, along the septum. TAPSE is a method to measure the distance of systolic excursion of the RV annular segment along its longitudinal plane, from a standard apical four-chamber window. The Tei index is a global estimate of both systolic and diastolic function of the right ventricle and was defined as [(isovolumic relaxation time + isovolumic contraction time)/ejection time]. Ejection time was measured using pulsed Doppler of RV outflow (time from the onset to the cessation of flow) and tricuspid valve closure-opening time was measured using continuous Doppler of the TR jet (time from the onset to the cessation of the jet). Isovolumic relaxation time and isovolumic contraction time were calculated by subtracting ejection time from TR jet time. TR severity was determined using an integrative, semiquantitative approach as recommended by the American Society of Echocardiography. We first assessed the severity of valve regurgitation by evaluating specific signs that would point to either less than mild or severe regurgitation, including color jet area (thin small central vs large >50% jet area), vena contracta (VC) width (<0.2 cm or $7 mm), density of continuous Doppler jet (faint or dense and triangular), hepatic vein flow pattern (systolic dominant vs systolic reversal), transtricuspid inflow pattern (A-wave dominant or high-velocity E-wave dominant), annular diameter (normal vs dilated annulus with lack of valve coaptation), and RV and right atrial (RA) size (normal vs dilated). If all of the signs and indices were concordant, we defined TR as less than mild or severe. If the signs or values of the qualitative or semiquantitative parameters were in the intermediate range between mild and severe, we defined TR as at least moderate to severe if the majority (five or more) of the signs and indices were concordant with severe TR. 15 Measurements of mitral inflow included the peak early filling (E-wave) and late diastolic filling (A-wave) velocities, the E/A ratio, and deceleration time of early filling velocity. Early diastolic mitral annular velocity (e 0 ) was measured in the apical four-chamber view. 16 In patients with atrial fibrillation, all measurements were averages of at least seven cardiac cycles. Left atrial volume was calculated using the biplane area-length method at end-systole. Cardiac structural as well as functional information was used to define whether PH was postcapillary (elevated left filling pressure) or precapillary (elevated pulmonary vascular resistance). Briefly, postcapillary PH was defined whenever left atrial maximal volume index was >34 mL/m 2 or LV mass exceeded the gender-specific normal range and E/A ratio was $2. Precapillary PH was defined whenever E/A ratio was #0.8, along with a peak E velocity < 50 cm/sec. In patients with E/A ratios # 0.8 with peak E velocities > 50 cm/sec, or E/A ratios between >0.8 and < 2, postcapillary PH was defined whenever the average E/e 0 ratio was >14 and left atrial maximal volume index was >34 mL/m 2 .
Statistical Analysis
Continuous normally distributed parameters are presented as mean 6 SD and were compared using Student's t test. Ordinal and/or skewed data are presented as median (interquartile range) and were compared using the Wilcoxon rank sum test. Categorical data were compared between groups using the c 2 test or Fisher exact test. Clinical end points were time to death and time to cardiac death. Univariate Cox proportional-hazard models for the end points allowed the calculation of hazard ratios (HRs) attached to routine echocardiographic and RV parameters. To assess if TR grade or VC was independently associated with outcome, we used multivariate Cox proportional-hazard models for the end points (time to death), allowing the calculation of HRs attached to at least moderate to severe TR adjusted for significant clinical variables or echocardiographic variables. The entry criterion was a univariate correlation with a P value < .05. To detect collinearity, we used correlation factor analyses to determine if any pairs of predictor variables were correlated with each other or with TR. The only highly correlated parameters (correlation coefficient > 0.9) were systolic pulmonary artery pressure and RA pressure. If any such pairs were found, the variable with the lowest univariate P value was chosen to be included in the analysis. Incremental value of VC versus TR grade, or jet area, and incremental value of TAPSE versus other RV functional parameters for assessment of time to clinical end points were tested by comparing nested models using F tests. Event distributions were calculated according to the Kaplan-Meier method and compared by means of the log-rank test. All P values were two sided, and P values < .05 were considered to indicate statistical significance. To assess thresholds of risk for TR VC, we used spline curves (of HR on the y axis vs TR VC on the x axis), whereby an HR of 1 represents the cohort's mean risk. All data were analyzed using the JMP version 12.0 (SAS Institute, Cary, NC). All authors participated in designing the study, collecting and analyzing data, and drafting and revising the manuscript.
RESULTS
Clinical and Echocardiographic Characteristics
Demographic laboratory and echocardiographic baseline parameters stratified by severity of TR are shown in Table 1 . Clinical parameters stratified by severity of TR are shown in Table 2 . The etiology for PH was precapillary in 74 patients (30%; connective tissue disease, n = 9; thromboembolic disease, n = 18; and chronic obstructive lung disease, n = 47) and postcapillary in 171 patients. There were no differences between the groups in etiology of PH (Table 2) . Compared with patients with less than mild TR, those with at least moderate to severe TR were significantly older and had increased prevalence of atrial fibrillation, increased New York Heart Association grade, reduced blood pressure, reduced cardiac output, higher pulmonary artery systolic pressure, and larger left atria. Physical examination findings indicated right heart failure more often in patients with at least moderate to severe TR. Most echocardiographic parameters of right heart dysfunction were poorer in the group with at least moderate to severe TR: larger RA area, higher estimated RA pressure, TAPSE, and larger RV area measurements. The Tei index and RV FAC values were similar in both TR groups.
Outcome Analysis
During the follow-up period (1.8 6 1.3 years), 28 deaths occurred in the less than mild group, six of which were cardiac deaths, and 105 in the at least moderate to severe TR group, with 39 of cardiac etiology. Clinical and echocardiographic parameters associated with mortality are shown in Table 3 .
Although RV FAC was associated with survival rate, addition of TAPSE in nested models eliminated the significance of RV FAC and improved model prediction (P < .05 for both).
The Kaplan-Meier curve for overall survival is shown in Figure 2A . Survival was significantly lower in patients with at least moderate to severe TR. The Kaplan-Meier curve for cardiac mortality is shown in Figure 2B . Cardiac-related mortality was significantly higher in patients with at least moderate to severe TR.
Multivariate Cox hazard analysis for TR grade, or VC, adjusted for significant clinical and echocardiographic parameters is shown in Table 4 . The mortality HRs of at least moderate to severe TR (1.7; 95% CI, 1.05-2.9; P = .03) and VC (1.06; 95% CI, 1.01-1.11; P = .02) remained significant even after adjustment for demographic, echocardiographic, and RV parameters.
Subgroup Analysis
Results of subgroup and interaction analyses are shown in Table 5 . Cox proportional-hazard analysis with interaction terms for TR grade and etiology of PH (pre-vs postcapillary) failed to detect a significant interaction between etiology of PH and outcome of TR. Cox proportional-hazard analysis in patients with postcapillary and precapillary PH showed an association of TR with mortality. Cox proportional-hazard analysis with interaction terms for TR grade and tricuspid annular diameter (<40 or $40 mm) failed to detect a significant interaction between tricuspid annular diameter and outcome of TR. Cox proportional-hazard analysis in patients with enlarged annuli ($40 mm) showed a significant association of TR with mortality (P = .01). Cox proportional-hazard analysis in patients with normal annular diameter (<40 mm) showed a nonsignificant association of TR with mortality (HR, 1.4; P = .10). Patients were also stratified by symptom status as asymptomatic (19%) or symptomatic (81%). Cox hazard analysis stratified by symptom status showed a significant interaction between symptom status and outcome of TR (P = .05 for interaction). Cox proportional-hazard analysis in patients with symptoms showed a significant association of TR with mortality (P = .002). Cox proportional-hazard analysis in asymptomatic patients failed to show a significant association with mortality (P = .40).
VC versus Qualitative Assessment
Although TR jet area and more than moderate TR by qualitative criteria were associated with a lower survival rate and higher cardiac mortality, for both end points, the addition of VC in nested models eliminated qualitative grading significance and improved model prediction (P < .05 for both). The pattern linking TR VC and mortality was analyzed in spline curves (of HR on the y axis vs TR VC on the x axis), whereby an HR of 1 represents the cohort's mean risk. The spline curve showed that TR VC negatively affected survival, with a threshold (crossing of the HR line of 1.0) of 6 mm. This threshold is similar to the threshold defined as associated with severe TR. 15 
DISCUSSION
Current guidelines
2 offer clear indications only for surgical correction of TR when surgery for left-sided valvular disease is the primary indication. Until recently, reparative or replacement surgery was the only intervention available. However, percutaneous repair procedures for TR are currently being avidly researched. [17] [18] [19] Although complication rate and selection criteria are still not available, patients who are at high risk for surgery may benefit from these less invasive interventions. In view of these new procedures it has become imperative to analyze the impact of TR on outcome. Nonetheless, assessing the clinical impact of TR is difficult, because it is heterogeneous, variably associated with intrinsic valve lesions, PH, ventricular dysfunction, and other comorbidities 20 that have confused previous attempts to define the TR-specific impact on outcome. 6 Targeting idiopathic TR showed TR to be associated with mortality even after adjusting for confounders. 10 However, other clinical scenarios have resulted in conflicting results. Specifically, TR caused by flail leaflets 8 and associated with rheumatic mitral disease 9 influenced survival, but TR after left heart valve procedures, 11 following transcatheter aortic valve replacement, 12 or associated with severe systolic dysfunction 13 was not an independent correlate of survival. In the present study, we wanted to single out patients with clinically significant isolated functional TR and preserved ejection fraction who have PH (pre-or postcapillary) that, other than causing TR, may have detrimental effect on natural survival and outcomes. 21 
Survival
Although seminal reports analyzing the impact of TR on outcome have resulted in conflicting results, 6, [8] [9] [10] [11] 13 the present study provides evidence that functional isolated TR is associated with excess mortality in the subgroup of patients with preserved left systolic function and PH, irrespective of etiology (heart failure with preserved LVEF or elevated pulmonary vascular resistance) even after adjusting for multiple other associates of mortality. In view of the observation, not affected by rhythm, RV dysfunction, or other comorbidities, of this strong link to TR outcome, future studies should examine whether these strong conclusions can be applied to other well-defined subsets of patients with TR. Importantly, no adverse consequence could be detected regarding at least moderate-severe TR (VC $ 6 mm) in asymptomatic patients with PH and preserved systolic function, suggesting that at least in this context, TR may be treated conservatively and emphasizing the importance of meticulous clinical assessment. Nevertheless, the lack of association between TR and mortality in asymptomatic patients should be interpreted cautiously because of the small number of patients, large CIs, and possible lack of power.
Assessment of TR
TR is often clinically unsuspected, 10 and cardiac auscultation is rarely typical. Thus, in routine practice, diagnosis depends mostly on echocardiography. For this purpose, we prefer semiquantitative grading of TR. The present data show that in patients with preserved left systolic function and PH, the prognostic power of VC supersedes that of classic qualitative grading or jet area. 15 Furthermore, our data show that in these patients, VC was associated with poorer survival only when $6 mm, similar to the threshold defined in recent guidelines. 15 Importantly, no adverse consequence could be detected regarding VC < 6 mm in the specific context of isolated functional TR associated with PH, suggesting that, in this context, VC < 6 mm can be treated conservatively and emphasizing the importance of TR semiquantitative assessment. However, although weaker, a qualitative definition of TR is also associated with adverse outcome and is important in alerting to the condition and to the need for quantitative or semiquantitative assessment. Importantly, TR severity may vary because of RV plasticity and varying load. RV widening and annular enlargement decrease systolic annular coverage by leaflets, increasing TR. Hence, persistence of severe functional TR despite treatment is important in therapeutic decisions. 22 
Assessment of RV Function
Patients with at least moderate to severe TR had poorer longitudinal RV function (TAPSE). Furthermore, low TAPSE and, to a lesser extent, low RV FAC were associated with increased mortality. TAPSE is a method to measure the distance of systolic excursion of the RV annular segment along its longitudinal plane. It is simple, is reproducible, does not require sophisticated equipment or prolonged image analysis, and correlates with RV ejection fraction. 23, 24 Although it assumes that the displacement of the basal and adjacent segments is representative of the function of the entire right ventricle, because regional RV wall motion abnormalities are rare in the context of PH or TR, TAPSE seems to be an ideal simple method for RV assessment in these patients.
On the other hand, the Tei index, another surrogate marker for ventricular function, was similar (<0.4) in both groups. The Tei index is affected by isovolumic relaxation time, which ends when the pressure in the right atrium increases above the systolic RV pressure. With TR, RA pressure increases rapidly during systole, so the duration of isovolumic relaxation shortens and may pseudonormalize the Tei index despite severe RV dysfunction. 25 On the basis of our data, we believe that TAPSE should be the method of choice for RV assessment in patients with PH and functional TR.
Clinical Implications
The present study provides innovative evidence that isolated functional TR, in symptomatic patients with preserved left systolic function and PH, is associated with excess mortality when it is at least moderate to severe (VC $ 6 mm), irrespective of whether PH is due to heart failure with preserved LVEF (postcapillary) or increased pulmonary vascular resistance (precapillary). Furthermore, we show that measurement of VC using semiquantitative Doppler echocardiographic methods provides superior tools for stratification and management and that a VC threshold of 6 mm is linked with survival. Importantly, no adverse consequence could be detected regarding lesser degree of TR (<6 mm), suggesting that in this context, TR can be treated conservatively and emphasizing the importance of precise TR assessment.
Study Limitations
This was a single-center, observational, retrospective study. Because of its retrospective nature, the study was subject to selection bias, and its results imply association, not cause and effect. Patients with at least moderate to severe TR were older and had numerous additional comorbidities compared with those with less than mild TR. We attempted to control for these differences by using adjusted analysis for systemic and cardiac comorbidities. Nevertheless, our results should be interpreted with caution and should serve as an incentive to explore the issue of the outcome of TR in the future with prospective randomized trials. Doppler echocardiography to assess systolic pulmonary pressure in the presence of severe TR may be questioned but is part of current guidelines. 26 The comprehensive multivariate mortality analysis is potentially overfitted, which may result in lower predictive performance. The lack of an interaction between etiology of PH, or annular diameter and outcome, and the lack of an association between TR and mortality in asymptomatic patients should be interpreted cautiously because of the small number of patients, large CIs, and possible lack of power. At the time of patient enrollment, routine RV assessment did not include magnetic resonance imaging, RV strain analysis, or three-dimensional RV ejection fraction, the prognostic value of which will warrant prospective studies of TR in the future. Guidelines do not provide class I indications for surgery of isolated, even severe, functional TR, and few patients were referred for surgery. We believe that our data support the rationale to consider surgery, or newer minimally invasive percutaneous approaches for significant functional TR, in the context of symptoms and PH, even if not associated with left-sided valve diseases, or left systolic dysfunction. Nevertheless, a clinical trial should be conducted to affirm the impact of tricuspid procedures on outcome.
CONCLUSIONS
In the context of preserved systolic function and PH, TR is associated with excess mortality even when adjusted for RV function and cardiac or systemic comorbidities irrespective of etiology (pre-or postcapillary) of PH. Semiquantitative assessment of TR by VC is a powerful independent associate of outcome, superior to standard qualitative assessment. 
